Abstract
Musculoskeletal disorders affect morbidity, quality of life and mortality, and represent an increasing economic and societal burden in the context of population aging and increased life expectancy. Improvement of quality of life should be one of the priorities of any interventions to prevent and treat musculoskeletal disorders in the ageing population. Two main approaches, namely generic and disease-specific instruments, can be applied to measure health-related quality of life. Among the generic tools available in scientific literature, the short form 36 questionnaire (SF-36) and the Euroqol five item questionnaire (EQ-5D) are two of the most popular questionnaires used to quantify the health related quality of life in people with musculoskeletal disorders. However, because generic tools may not always be able to detect subtle effects of a specific condition on quality of life, a specific tool is highly valuable. Specific tools improve the ability to clinically characterize quality of life in subjects with a specific musculoskeletal disorder, as well as the capacity to assess changes over time in the QoL of these subjects. The recent development of specific tools should help to validate preventive and therapeutic interventions in this field.
Similar content being viewed by others
References
Hoy DG, Smith E, Cross M et al (2014) The global burden of musculoskeletal conditions for 2010: an overview of methods. Ann Rheum Dis 73:982–989
Prince MJ, Wu F, Guo Y et al (2015) The burden of disease in older people and implications for health policy and practice. Lancet 385:549–562
Chatterji S, Byles J, Cutler D et al (2015) Health, functioning, and disability in older adults–present status and future implications. Lancet 385:563–575
March L, Smith EUR, Hoy DG et al (2014) Burden of disability due to musculoskeletal (MSK) disorders. Best Pract Res Clin Rheumatol 28:353–366
Murray CJL, Barber RM, Foreman KJ et al (2015) Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 386:2145–2191
Beaudart C, Zaaria M, Pasleau F et al (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One Public Libr Sci 12:e0169548
Cesari M, Landi F, Calvani R et al (2017) Rationale for a preliminary operational definition of physical frailty and sarcopenia in the SPRINTT trial. Aging Clin Exp Res 29:81–88
Marzetti E, Calvani R, Tosato M et al (2017) Sarcopenia: an overview. Aging Clin Exp Res 29:11–17
Cruz-Jentoft AJ, Kiesswetter E, Drey M et al (2017) Nutrition, frailty, and sarcopenia. Aging Clin Exp Res 29:43–48
Bartley MM, Geda YE, Christianson TJH et al (2016) Frailty and mortality outcomes in cognitively normal older people: sex differences in a population-based study. J Am Geriatr Soc 64:132–137
Dawson A, Dennison E (2016) Measuring the musculoskeletal aging phenotype. Maturitas 93:13–17
Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet (London, England) 359:1761–1767
Cross M, Smith E, Hoy D et al (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73:1323–1330
Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16:S3–S7
Lippuner K, Johansson H, Kanis JA et al (2009) Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int 20:1131–1140
Hars M, Biver E, Chevalley T et al (2016) Low lean mass predicts incident fractures independently from FRAX: a prospective cohort study of recent retirees. J Bone Miner Res 31:2048–2056
Scott D, Chandrasekara SD, Laslett LL et al (2016) Associations of sarcopenic obesity and dynapenic obesity with bone mineral density and incident fractures over 5–10 years in community-dwelling older adults. Calcif Tissue Int 99:30–42
Bischoff-Ferrari HA, Orav JE, Kanis JA et al (2015) Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int 26:2793–2802
Beaudart C, Rizzoli R, Bruyère O et al (2014) Sarcopenia: burden and challenges for public health. Arch Public Health 72:45
Xie F, Kovic B, Jin X et al (2016) Economic and humanistic burden of osteoarthritis: a systematic review of large sample studies. Pharmacoeconomics 34:1087–1100
Abimanyi-Ochom J, Watts JJ, Borgström F et al (2015) Changes in quality of life associated with fragility fractures: Australian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (AusICUROS). Osteoporos Int 26:1781–1790
Tarride J-E, Burke N, Leslie WD et al (2016) Loss of health related quality of life following low-trauma fractures in the elderly. BMC Geriatr 16:84
Al-Sari UA, Tobias J, Clark E (2016) Health-related quality of life in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis. Osteoporos Int 27:2891–2900
Yu W-Y, Hwang H-F, Hu M-H et al (2013) Effects of fall injury type and discharge placement on mortality, hospitalization, falls, and ADL changes among older people in Taiwan. Accid Anal Prev 50:887–894
Dyer SM, Crotty M, Fairhall N et al (2016) A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr 16:158
Leslie WD, Lix LM, Finlayson GS et al (2013) Direct healthcare costs for 5 years post-fracture in Canada: a long-term population-based assessment. Osteoporos Int 24:1697–1705
Leal J, Gray AM, Prieto-Alhambra D et al (2016) Impact of hip fracture on hospital care costs: a population-based study. Osteoporos Int 27:549–558
Lippuner K, Golder M, Greiner R (2005) Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland. Osteoporos Int 16:S8–S17
Svedbom A, Ivergård M, Hernlund E et al (2014) Epidemiology and economic burden of osteoporosis in Switzerland. Arch Osteoporos 9:187
Morin S, Lix LM, Azimaee M et al (2012) Institutionalization following incident non-traumatic fractures in community-dwelling men and women. Osteoporos Int 23:2381–2386
Gill TM, Murphy TE, Gahbauer EA et al (2013) Association of injurious falls with disability outcomes and nursing home admissions in community-living older persons. Am J Epidemiol 178:418–425
Verlaan S, Aspray TJ, Bauer JM et al (2017) Nutritional status, body composition, and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults: a case-control study. Clin Nutr 36:267–274
Filippin LI, Teixeira VN de O, da Silva MPM, Miraglia F, da Silva FS (2015) Sarcopenia: a predictor of mortality and the need for early diagnosis and intervention. Aging Clin Exp Res 27:249–254
Cawthon PM, Lui L-Y, McCulloch CE et al (2016) Sarcopenia and health care utilization in older women. J Gerontol A Biol Sci Med Sci 2016:glw118
Morin S, Lix LM, Azimaee M et al (2011) Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int 22:2439–2448
Bliuc D, Nguyen ND, Milch VE et al (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521
von Friesendorff M, McGuigan FE, Wizert A et al (2016) Hip fracture, mortality risk, and cause of death over two decades. Osteoporos Int 27:2945–2953
Kluzek S, Sanchez-Santos MT, Leyland KM et al (2016) Painful knee but not hand osteoarthritis is an independent predictor of mortality over 23 years follow-up of a population-based cohort of middle-aged women. Ann Rheum Dis 75:1749–1756
De Buyser SL, Petrovic M, Taes YE et al (2016) Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older men. Age Ageing 45:602–608
Ensrud KE, Lui L-Y, Paudel ML et al (2016) Effects of mobility and cognition on risk of mortality in women in late life: a prospective study. J Gerontol A Biol Sci Med Sci 71:759–765
Briggs AM, Cross MJ, Hoy DG et al Musculoskeletal health conditions represent a global threat to healthy aging: a report for the 2015 World Health Organization World Report on Ageing and Health
Revicki DA, Osoba D, Fairclough D et al (2000) Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 9:887–900
Ul-Haq Z, Mackay DF, Pell JP et al (2014) Association between physical and mental health-related quality of life and adverse outcomes; a retrospective cohort study of 5,272 Scottish adults. BMC Public Health 14:1197
Trombetti A, Reid KF, Hars M et al (2016) Age-associated declines in muscle mass, strength, power, and physical performance: impact on fear of falling and quality of life. Osteoporos Int 27:463–471
Nglazi MD, West SJ, Dave JA et al (2014) Quality of life in individuals living with HIV/AIDS attending a public sector antiretroviral service in Cape Town, South Africa. BMC Public Health 14:676
Zhou J, Ru X, Hearst N et al (2014) Individual and household-level predictors of health related quality of life among middle-aged people in rural Mid-east China: a cross-sectional study. BMC Public Health 14:660
Guyatt GH, Bombardier C, Tugwell PX (1986) Measuring disease-specific quality of life in clinical trials. CMAJ 134:889–895
Rizzoli R, Reginster JY, Arnal JF et al (2013) Quality of life in sarcopenia and frailty. Calcif Tissue Int 93:101–120
Syddall HE, Martin HJ, Harwood RH et al (2009) The SF-36: a simple, effective measure of mobility-disability for epidemiological studies. J Nutr Health Aging 13:57–62
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483
Rabin R, de Charro F (2001) EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33:337–343
Ahrens C, Schiltenwolf M, Wang H (2010) Health-related quality of life (SF-36) in chronic low back pain and comorbid depression. Schmerz 24:251–256
Adorno MLGR, Brasil-Neto JP (2013) Assessment of the quality of life through the SF-36 questionnaire in patients with chronic nonspecific low back pain. Acta Ortop Bras Braz Soc Orthop Traumatol 21:202–207
Veresciagina K, Ambrozaitis KV, Spakauskas B (2007) Health-related quality-of-life assessment in patients with low back pain using SF-36 questionnaire. Medicina (B Aires) 43:607–613
Talamo J, Frater A, Gallivan S et al (1997) Use of the short form 36 (SF36) for health status measurement in rheumatoid arthritis. Rheumatology 36:463–469
Kosinski M, Keller SD, Ware JE et al (1999) The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care 37:MS23–MS39
Hill CL, Parsons J, Taylor A et al (1999) Health related quality of life in a population sample with arthritis. J Rheumatol 26:2029–2035
Angst F, Aeschlimann A, Steiner W et al (2001) Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention. Ann Rheum Dis BMJ Group 60:834–840
Matcham F, Scott IC, Rayner L et al (2014) The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: A systematic review and meta-analysis. Semin Arthritis Rheum 44:123–130
Zanoli G, Jönsson B, Strömqvist B (2006) SF-36 scores in degenerative lumbar spine disorders: analysis of prospective data from 451 patients. Acta Orthop 77:298–306
Guilfoyle MR, Seeley H, Laing RJ (2009) The Short Form 36 health survey in spine disease–validation against condition-specific measures. Br J Neurosurg 23:401–405
Neumann L, Berzak A, Buskila D (2000) Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36). Semin Arthritis Rheum 29:400–408
Salaffi F, Sarzi-Puttini P, Girolimetti R et al (2009) Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol 27:S67–S74
Beaudart C, Reginster JY, Petermans J et al (2015) Quality of life and physical components linked to sarcopenia: the SarcoPhAge study. Exp Gerontol 69:103–110
Yadav A, Chang Y-H, Carpenter S et al (2015) Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates. Clin Transplant 29:134–141
Silva Neto LS, Karnikowiski MG, Tavares AB et al (2012) Association between sarcopenia, sarcopenic obesity, muscle strength and quality of life variables in elderly women. Rev Bras Fisioter 16:360–367
Johnsen LG, Hellum C, Nygaard ØP et al (2013) Comparison of the SF6D, the EQ5D, and the oswestry disability index in patients with chronic low back pain and degenerative disc disease. BMC Musculoskelet Disord 14:148
Whynes DK, McCahon RA, Ravenscroft A et al (2013) Responsiveness of the EQ-5D health-related quality-of-life instrument in assessing low back pain. Value Health 16:124–132
Fransen M, Edmonds J (1999) Reliability and validity of the EuroQol in patients with osteoarthritis of the knee. Rheumatology 38:807–813
Hernandez Alava M, Wailoo A, Wolfe F et al (2013) The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis. Rheumatology 52:944–950
Hurst NP, Kind P, Ruta D et al (1997) Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Rheumatology 36:551–559
Go SW, Cha YH, Lee JA et al (2013) Association between sarcopenia, bone density, and health-related quality of life in Korean Men. Korean J Fam Med 34:281–288
Wolfe F, Hawley DJ (1997) Measurement of the quality of life in rheumatic disorders using the EuroQol. Br J Rheumatol 36:786–793
Picavet HSJ, Hoeymans N (2004) Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study. Ann Rheum Dis BMJ Group 63:723–729
Ware JE Jr (1996) The SF-36 Health Survey. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven, Philadalphia, pp 337–344
Lips P, Cooper C, Agnusdei D et al (1999) Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int 10:150–160
Marquis P, Cialdella P, De la Loge C (2001) Development and validation of a specific quality of life module in post-menopausal women with osteoporosis: the QUALIOST. Qual Life Res 10:555–566
Randell AG, Bhalerao N, Nguyen TV et al (1998) Quality of life in osteoporosis: reliability, consistency, and validity of the Osteoporosis Assessment Questionnaire. J Rheumatol 25:1171–1179
Measuring quality of life in women with osteoporosis (1997) Osteoporosis Quality of Life Study Group. Osteoporos Int 7:478–487
Helmes E, Hodsman A, Lazowski D et al (1995) A questionnaire to evaluate disability in osteoporotic patients with vertebral compression fractures. J Gerontol A Biol Sci Med Sci 50:M91–M98
Lydick E, Zimmerman SI, Yawn B et al (1997) Development and validation of a discriminative quality of life questionnaire for osteoporosis (the OPTQoL). J Bone Miner Res 12:456–463
Tijhuis GJ, Jong Z de, Zwinderman AH et al (2001) The validity of the rheumatoid arthritis quality of life (RAQoL) questionnaire. Rheumatology 40:1112–1119
Rat A-C, Coste J, Pouchot J et al (2005) OAKHQOL: a new instrument to measure quality of life in knee and hip osteoarthritis. J Clin Epidemiol 58:47–55
McKenna SP, Doward LC, Whalley D et al (2004) Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis BMJ Group 63:162–169
Beaudart C, Biver E, Reginster J-Y et al (2015) Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing 44:960–966
Bennett RM, Friend R, Jones KD et al (2009) The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 11:R120
Reginster J-Y, Cooper C, Rizzoli R et al (2016) Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clin Exp Res 28:47–58
Landi F, Cesari M, Calvani R et al (2017) The sarcopenia and physical fRailty IN older people: multi-componenT Treatment strategies? (SPRINTT) randomized controlled trial: design and methods. Aging Clin Exp Res 29:89–100
Acknowledgements
We thank the Prince Mutaib Bin Abdullah Chair for Biomarkers of Osteoporosis and Deanship of Scientific Research, King Saud University for their support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Charlotte Beaudart, Olivier Bruyère and Jean-Yves Reginster are the shareholders of SarQoL® sprl. Others authors have no relevant competing interests to declare.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study informed consent is not required.
Additional information
Charlotte Beaudart and Emmanuel Biver Co-first authors.
Rights and permissions
About this article
Cite this article
Beaudart, C., Biver, E., Bruyère, O. et al. Quality of life assessment in musculo-skeletal health. Aging Clin Exp Res 30, 413–418 (2018). https://doi.org/10.1007/s40520-017-0794-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-017-0794-8